Insulin Injection Frequency: Regimens for Type 1 and Type 2 Diabetes

Insulin dosing frequency is individualized based on diabetes type, regimen, lifestyle, and glycemic targets.

Type 1 Diabetes (Absolute Insulin Deficiency)

  • Basal-bolus (MDI): Long-acting basal (glargine, detemir, degludec) once/twice daily + rapid-acting bolus (lispro, aspart, glulisine) before each meal = 4–6+ injections/day.
  • Insulin pump (CSII): Continuous basal + bolus via infusion set; no injections.
  • Premixed (rarely used now): BID fixed ratio; less flexible.

Type 2 Diabetes (Progressive β-Cell Failure)

  • Basal only: Long-acting once daily (often bedtime) + oral agents.
  • Basal + 1–3 bolus: Add prandial insulin for postprandial control.
  • Premixed BID: Convenient but rigid; higher hypoglycemia risk.
  • Concentrated insulins (U-200, U-300, U-500): For high-dose resistance; volume reduction.

Key Principles

  • Titrate to target (fasting 80–130, postprandial <180 mg/dL; individualized).
  • Rotate sites (abdomen, thigh, buttock, arm) — lipohypertrophy impairs absorption.
  • Monitor: SMBG or CGM; adjust per pattern.
  • Hypoglycemia prevention: Education, glucagon, carb counting, pump suspend.

Regimen choice shared between patient and diabetes team. Technology (CGM, pumps, smart pens) improves precision and quality of life.

Diabetes - Related Articles